2009 A(H1N1) Seroconversion Rates and Risk Factors among the General Population in Vientiane Capital, Laos

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kieffer, Alexia ^a,c   Paboriboune, Phimpha ^b   Crépey, Pascal ^a,c   Flaissier, Bruno ^c   Souvong, Vimalay ^b   Steenkeste, Nicolas ^d   Salez, Nicolas ^a   Babin, François Xavier ^d   Longuet, Christophe ^d   Carrat, Fabrice ^e   Flahault, Antoine ^c   de Lamballerie, Xavier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Centre d Infectiologie Christophe Mérieux du Laos   (Laos)

^c EHESP   (France)

^d Fondation Merieux   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DEMOGRAPHY; DEVELOPED COUNTRY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HOUSEHOLD; HUMAN; IMMUNITY; INFANT; INFECTION RATE; LAOS; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SOCIAL ASPECT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LAOS; MALE; MIDDLE AGED; PANDEMICS; RISK FACTORS; SEASONS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 84876316512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061909     Document Type: Article

References (57)

1. Moura FE, (2010) Influenza in the tropics. Current opinion in infectious diseases 23: 415-420.
2. Hanvoravongchai P, Adisasmito W, Chau PN, Conseil A, De Sa J, et al. (2010) Pandemic influenza preparedness and health systems challenges in Asia: results from rapid analyses in 6 Asian countries. BMC public health 10: 322.
3. Vongphrachanh P, Simmerman JM, Phonekeo D, Pansayavong V, Sisouk T, et al. (2010) An early report from newly established laboratory-based influenza surveillance in Lao PDR. Influenza and other respiratory viruses 4: 47-52.
4. WHO (2009) Human infections of influenza A (H1N1): Perspective from WHO Lao P.D.R. (update 22). Available: www.unlao.org/H1N1/influenzah1n1.asp. Accessed 20 March 2013.
5. WHO (2010) Influenza Update: Perspective from WHO Lao P.D.R. (update 40). Available: www.unlao.org/H1N1/influenzah1n1.asp. Accessed 20 March 2013.
6. Lapidus N, De Lamballerie X, Salez N, Setbon M, Ferrari P, et al. (2012) Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC public health 12: 417.
7. Dellagi K, Rollot O, Temmam S, Salez N, Guernier V, et al. (2011) Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009. PLoS one 6: e25738.
8. Koita OA, Sangare L, Poudiougou B, Aboubacar B, Samake Y, et al. (2012) A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali. Clinical Microbiology and Infection 18: 976-981.
9. Vallée J, Dubot-Pérès A, Ounaphom P, Sayavong C, Bryant JE, et al. (2009) Spatial distribution and risk factors of dengue and Japanese encephalitis virus infection in urban settings: the case of Vientiane, Lao PDR. Tropical medicine & international health 14: 1134-1142.
10. Vallée J, Souris M, Fournet F, Bochaton A, Mobillion V, et al. (2007) Sampling in health geography: reconciling geographical objectives and probabilistic methods. An example of a health survey in Vientiane (Lao PDR). Emerging themes in epidemiology 4: 6.
11. Vallée J, Thaojaikong T, Moore CE, Phetsouvanh R, Richards AL, et al. (2010) Contrasting spatial distribution and risk factors for past infection with scrub typhus and murine typhus in Vientiane City, Lao PDR. PLoS neglected tropical diseases 4: e909.
12. Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, et al. (2011) Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clinical Microbiology and Infection 18: 177-183.
13. Nauta JJP, (2006) Eliminating bias in the estimation of the geometric mean of HI titres. Biologicals: journal of the International Association of Biological Standardization 34: 183-186.
14. Stephenson I, (2009) Reproducibility of Serologic Assays for Influenza Virus A (H5N1). Emerging Infectious Diseases 15: 1251-1259.
15. Wood J, Gaines-Das R, Taylor J, Chakraverty P, (1994) Comparison of influenza serological techniques by international collaborative study. Vaccine 12: 167-174.
16. Broberg E, Nicoll A, Amato-Gauci A, (2011) Seroprevalence to influenza A(H1N1) 2009 virus- where are we? Clinical and vaccine immunology 18: 1205-1212.
17. Achonu C, Rosella L, Gubbay JB, Deeks S, Rebbapragada A, et al. (2011) Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS one 6: e26427.
18. Wu JT, Ma ESK, Lee CK, Chu DKW, Ho P, et al. (2010) The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong. Clinical Infectious Diseases 51: 1184-1191.
19. Chao D-Y, Cheng K-F, Li T-C, Wu T-N, Chen C-Y, et al. (2011) Serological Evidence of Subclinical Transmission of the 2009 Pandemic H1N1 Influenza Virus Outside of Mexico. PLoS one 6: e14555.
20. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, et al. (2011) Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study. PLoS medicine 8: e1000442.
21. Yang P, Zhang L, Shi W, Lu G, Cui S, et al. (2012) Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China. Influenza and Other Respiratory Viruses 6: 381-388.
22. Kok J, Tudo K, Blyth CC, Foo H, Hueston L, et al. (2011) Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals. Journal of acquired immune deficiency syndromes (1999) 56: 91-94.
23. Chen MIC, Lee VJM, Lim W-Y, Barr IG, Lin RTP, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303: 1383-1391.
24. Chen MIC, Lee VJM, Barr I, Lin C, Goh R, et al. (2010) Risk Factors for Pandemic (H1N1) 2009 Virus Seroconversion among Hospital Staff, Singapore. Emerging Infectious Diseases 16Available: http://www.cdc.gov/eid/content/16/10/1554.htm. Accessed 23 November 2012.
25. Kok J, Dwyer DE, Dywer DE, (2011) How common was 2009 pandemic influenza A H1N1? The Lancet infectious diseases 11: 423-424.
26. Park AW, Glass K, (2007) Dynamic patterns of avian and human influenza in east and southeast Asia. The Lancet infectious diseases 7: 543-548.
27. Blair PJ, Wierzba TF, Touch S, Vonthanak S, Xu X, et al. (2010) Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. Epidemiology and infection 138: 199-209.
28. Simmerman JM, Uyeki TM, (2008) The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza and other respiratory viruses 2: 81-92.
29. WHO (2010) Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Weekly Epidemiological Record 24: 229-236.
30. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic. PLoS one 5: e13211.
31. Dowse GK, Smith DW, Kelly H, Barr I, Laurie KL, et al. (2011) Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia- a seroprevalence study. The Medical journal of Australia 194: 68-72.
32. Gilbert GL, Cretikos M a, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter. PLoS one 5: e12562.
33. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
34. Mak GC, Choy PWW, Lee WY, Wong AH, Ng KC, et al. (2010) Sero-Immunity and Serologic Response to Pandemic Influenza A (H1N1) 2009 Virus in Hong Kong. Journal of Medical Virology 1815: 1809-1815.
35. Tandale B V, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, et al. (2010) Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC infectious diseases 10: 255.
36. Waalen K, Kilander a, Dudman SG, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro surveillance 15: 1-6 Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19633. Accessed 20 March 2013.
37. Xu C, Bai T, Luliano AD, Wang M, Yang L, et al. (2011) The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China. PLoS one 6: e17919.
38. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS one 5: e11601.
39. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
40. Hardelid P, Andrews N, Hoschler K, Stanford E, Baguelin M, et al. (2010) Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technology Assessment 14: 115-192.
41. Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, et al. (2011) Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 29: 6664-6669.
42. Smith K, Warner P, Williams LJ, Adamson WE, Katikireddi SV, et al. (2011) Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic. Journal of environmental and public health 2011. doi: 10.1155/2011/407505.
43. McCullers JA, Van De Velde L-A, Allison KJ, Branum KC, Webby RJ, et al. (2010) Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clinical infectious diseases 50: 1487-1492.
44. McVernon J, Laurie K, Nolan T, Owen R, Irving D, et al. (2010) Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October- December 2009. Euro surveillance 15Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19678. Accessed 20 March 2013.
45. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-3562.
46. Chang S-C, Chang C-M, Huang Y-C, Chiu C-H, Shih S-R, et al. (2010) Preexisting Antibodies against Pandemic 2009 Influenza A (H1N1) Virus in Taiwan. Clinical infectious diseases 51: 1463-1465.
47. CDC (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 58: 521-524.
48. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW, (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Medical microbiology and immunology 199: 117-121.
49. Huang DT-N, Shao P-L, Huang K-C, Lu C-Y, Wang J-R, et al. (2011) Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerging infectious diseases 17: 76-78.
50. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. The New England journal of medicine 361: 1945-1952.
51. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro surveillance 15Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19478. Accessed 20 March 2013.
52. Chi C-Y, Liu C-C, Lin C-C, Wang H-C, Cheng Y-T, et al. (2010) Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population. Clinical and vaccine immunology 17: 1958-1962.
53. Chen H, (2009) Serologic Survey of Pandemic (H1N1) 2009 Virus, Guangxi Province, China. Emerging Infectious Diseases 15: 3-4.
54. Tang JW, Tambyah PA, Wilder-Smith A, Puong K-Y, Shaw R, et al. (2010) Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, Singapore. Emerging Infectious Diseases 16: 2009-2011.
55. Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, et al. (2011) Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proceedings of the National Academy of Sciences of the United States of America 108: 2825-2830.
56. Cauchemez S, Donnelly C, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. The New England journal of medicine 361: 2619-2627.
57. Yee BWK (1997) The Social and Cultural Context of Adaptive Aging by Southeast Asian Elders. Web Book available at: www.stpt.usf.edu/~jsokolov/webbook/yee.htm. Accessed 20 March 2013.